1. |
王玉琦, 岳嘉宁, 符伟国. 下肢动脉硬化闭塞症的外科治疗进展[J]. 中华临床医师杂志(电子版), 2009, 3(2):179-183.
|
2. |
刘昌伟. 下肢动脉硬化闭塞症的外科治疗[J]. 临床外科杂志,2006, 14(5):265-266.
|
3. |
Aronow WS. Peripheral arterial disease of the lower extremities[J]. Arch Med Sci, 2012, 8(2): 375-388.
|
4. |
Sundblad V, Croci DO, Rabinovich GA. Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues[J]. Histol Histopathol, 2011, 26(2):247-265.
|
5. |
Dumic J, Dabelic S, Flögel M. Galectins:an open-ended story[J]. Biochim Biophys Acta, 2006, 1760(4): 616-635.
|
6. |
Yang RY, Rabinovich GA, Liu FT. Galectins:structure, function and therapeutic potential[J]. Expert Rev Mol Med, 2008, 10:e17.
|
7. |
Idikio HA. Galectin-3 and Beclin1/Atg6 genes in human cancers:using cDNA tissue panel, qRT-PCR, and logistic regression modelto identify cancer cell biomarkers[J]. Plos One, 2011, 6(10):e26150.
|
8. |
Jara LJ, Medina G, Vera-Lastra O, et al. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases[J]. Autoimmun Rev, 2006, 5(3):195-201.
|
9. |
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9):1135-1143.
|
10. |
Hsu DK, Hammes SR, Kuwabara I, et al. Human T lymphotropicvirus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3[J]. Am J Pathol, 1996,148(5):1661-1670.
|
11. |
Kimata H. Enhancement of IgE production in B cells by neutrophils via galectin-3 in IgE-associated atopic eczema/dermatitis syndrome[J]. Int Arch Allergy Immunol, 2002, 128(2):168-170.
|
12. |
Fermino ML, Polli CD, Toledo KA, et al. LPS-induced galectin-3 oligomerization results in enhancement of neutrophil activation[J]. PloS One, 2011, 6(10): e20064.
|
13. |
Novak R, Dabelic S, Dumic J. Galectin-1 and galectin-3 expre-ssion profiles in classically and alternatively activated human macrophages[J]. Biochim Biophys Acta, 2012, 1820(9): 1383-1390.
|
14. |
Paclik D, Werner L, Guckelberger O, et al. Galectins distinctively regulate central monocyte and macrophage function[J]. Cell Immunol, 2011, 271(1): 97-103.
|
15. |
Papaspyridonos M, McNeill E, de Bono JP, et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progressionthrough macrophage activation and monocyte chemoattraction[J]. Arterioscler Thromb Vasc Biol, 2008, 28(3): 433-440.
|
16. |
Sano H, Hsu DK, Apgar JR, et al. Critical role of galectin-3 in phagocytosis by macrophages[J]. J Clin Invest, 2003, 112(3): 389-397.
|
17. |
Sano H, Hsu DK, Yu L, et al. Human galectin-3 is a novelchemoattractant for monocytes and macrophages[J]. J Immunol,.
|
18. |
Nachtigal M, Al-Assaad Z, Mayer EP, et al. Galectin-3 expression in human atherosclerotic lesions[J]. Am J Pathol, 1998, 152(5): 1199-1208.
|
19. |
Falcone C, Lucibello S, Mazzucchelli I, et al. Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome[J]. Int J Immunopathol Pharmacol, 2011, 24(4):905-913.
|
20. |
Vlassara H, Li YM, Imani F, et al. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products(AGE):a new member of the AGE-receptor complex[J]. Mol Med ,1995, 1(6):634-646.
|
21. |
Ahmad N, Gabius HJ, André S, et al. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes[J]. J Biol Chem, 2004, 279(12):10841–10847.
|
22. |
Califice S, Castronovo V, Van Den Brûle F. Galectin-3 and cancer(Review)[J]. Int J Oncol, 2004, 25(4):983-992.
|
23. |
Ferrazzo KL, Neto MM, dos Santos E, et al. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands[J]. J Oral Pathol Med, 2009, 38(9): 701-707.
|
24. |
Lee JH, Zhang X, Shin BK, et al. Mac-2 binding protein andgalectin-3 expression in mucinous tumours of the ovary:an anne-aling control primer system and immunohistochemical study[J]. Pathology, 2009, 41(3): 229-233.
|
25. |
Miranda FA, Hassumi MK, Guimaraes MC, et al. Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis[J]. J Histochem Cytochem, 2009, 57(7):665-673.
|
26. |
Nangia-Makker P, Balan V, Raz A. Galectin-3 binding andmetastasis[J]. Methods Mol Biol, 2012, 878: 251-266.
|
27. |
Shoeppner HL, Raz A, Ho SB, et al. Expression of an endogenous galactoside-binding lectin correlates with neoplastic progression in the colon[J]. Cancer, 1995, 75(12):2818-2826.
|
28. |
Xu XC, el-Nagger AK, Lotan R. Differential expression of gale-ctin-1 and galectin-3 in thyroid tumors:potential diagnostic impli-cations[J]. Am J Pathol, 1995, 147(3): 815-822.
|
29. |
Bresalier RS, Mazurek N, Sternberg LR, et al. Metastasis of human colon cancer is altered by modifying expression of the b galactoside-binding protein galectin-3[J]. Gastroenterology, 1998, 115(2):287-296.
|
30. |
Scott A, Mellor H. VEGF receptor trafficking in angiogenesis[J]. Biochem Soc Trans, 2009, 37(Pt 6):1184-1188.
|
31. |
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors[J]. Nat Med, 2003, 9(6): 669-676.
|
32. |
Markowska AI, Liu FT, Panjwani N. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenesis[J]. J Exp Med, 2010, 207(9): 1981-1993.
|
33. |
Takahashi T, Yamaguchi S, Chida K, et al. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelialcells[J]. EMBO J, 2001, 20(11):2768-2778.
|
34. |
Markowska AI, Jefferise KC, Panjwani N. Galectin-3 protein modulates cell surface expression and activation of vascularendothelial growth factor receptor 2 in human endothelial cells[J]. J Biol Chem, 2011, 286(34): 29913-29921.
|
35. |
Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis[J]. Am J Pathol, 2000, 156(3):899-909.
|
36. |
Saint-Lu N, Oortwijn BD, Pengon JN, et al. Identification ofgalectin-1 and galectin-3 as novel partners for von Willebrand factor[J]. Arterioscler Thromb Vasc Biol, 2012, 32(4):894-901.
|
37. |
Stowell SR, Arthur CM, Mehta P, et al. Galectin-1, -2, and-3exhibit differential recognition of sialylated glycans and blood group antigens[J]. J Biol Chem, 2008, 283(15):10109-10123.
|
38. |
, 165(4): 2156–2164.
|